Suven Life Sciences Limited (SUVEN.BO)

INR 142.95

(-0.56%)

Long Term Debt Summary of Suven Life Sciences Limited

  • Suven Life Sciences Limited's latest annual long term debt in 2023 was - INR , down -100.0% from previous year.
  • Suven Life Sciences Limited's latest quarterly long term debt in 2024 Q1 was - INR , down 0.0% from previous quarter.
  • Suven Life Sciences Limited reported annual long term debt of 5.79 Million INR in 2022, down -63.18% from previous year.
  • Suven Life Sciences Limited reported annual long term debt of 15.73 Million INR in 2021, down -42.14% from previous year.
  • Suven Life Sciences Limited reported quarterly long term debt of - INR for 2024 Q1, down 0.0% from previous quarter.
  • Suven Life Sciences Limited reported quarterly long term debt of - INR for 2023 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Suven Life Sciences Limited (2023 - 2004)

Historical Annual Long Term Debt of Suven Life Sciences Limited (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 - INR -100.0%
2022 5.79 Million INR -63.18%
2021 15.73 Million INR -42.14%
2020 27.18 Million INR -32.37%
2019 40.19 Million INR 126.42%
2018 17.75 Million INR -20.2%
2017 22.24 Million INR -91.42%
2016 259.32 Million INR -37.72%
2015 416.38 Million INR -29.9%
2014 594.02 Million INR 57.44%
2013 377.29 Million INR -41.22%
2012 641.83 Million INR 16.64%
2011 550.24 Million INR 57.49%
2010 349.39 Million INR -30.21%
2009 500.62 Million INR 16.13%
2008 431.1 Million INR -21.07%
2007 546.15 Million INR 31.63%
2006 414.9 Million INR 75.23%
2005 236.77 Million INR 19.55%
2004 198.05 Million INR 0.0%

Peer Long Term Debt Comparison of Suven Life Sciences Limited

Name Long Term Debt Long Term Debt Difference
Ajanta Pharma Limited 235.2 Million INR 100.0%
Amrutanjan Health Care Limited 13.96 Million INR 100.0%
Sigachi Industries Limited 265.79 Million INR 100.0%
Bal Pharma Limited 363.82 Million INR 100.0%
Ind-Swift Laboratories Limited 111.62 Million INR 100.0%
Medico Remedies Limited 8.67 Million INR 100.0%
Lasa Supergenerics Limited - INR NaN%
Venus Remedies Limited 386.8 Million INR 100.0%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 100.0%
Alpa Laboratories Limited - INR NaN%
Nectar Lifesciences Limited 1.4 Billion INR 100.0%
Shilpa Medicare Limited 5.6 Billion INR 100.0%
Aarti Drugs Limited 2.75 Billion INR 100.0%
Lupin Limited 1.55 Billion INR 100.0%
Aurobindo Pharma Limited 21.34 Billion INR 100.0%
Zydus Lifesciences Limited 251 Million INR 100.0%
Windlas Biotech Limited 20.18 Million INR 100.0%
Eris Lifesciences Limited 6.54 Billion INR 100.0%
Valiant Laboratories Limited 746.63 Million INR 100.0%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 100.0%
Solara Active Pharma Sciences Limited 1.05 Billion INR 100.0%
Ipca Laboratories Limited 5.8 Billion INR 100.0%
Bliss GVS Pharma Limited 355.92 Million INR 100.0%
Achyut Healthcare Limited - INR NaN%
Sun Pharmaceutical Industries Limited 13.3 Million INR 100.0%
Bajaj HealthCare Limited 650.34 Million INR 100.0%
RPG Life Sciences Limited -30.3 Million INR 100.0%
Mankind Pharma Limited 248.67 Million INR 100.0%
Laurus Labs Limited 8.6 Billion INR 100.0%
Piramal Pharma Limited 24.83 Billion INR 100.0%
Syncom Formulations (India) Limited -1.21 Million INR 100.0%
Torrent Pharmaceuticals Limited 16.04 Billion INR 100.0%
Alembic Pharmaceuticals Limited 628.8 Million INR 100.0%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 100.0%
Unichem Laboratories Limited 382.22 Million INR 100.0%
Sequent Scientific Limited 1.42 Billion INR 100.0%
Novartis India Limited 50.7 Million INR 100.0%
Wanbury Limited 820 Million INR 100.0%
Suven Pharmaceuticals Limited 212.35 Million INR 100.0%
Wockhardt Limited 8.91 Billion INR 100.0%
Themis Medicare Limited 267.74 Million INR 100.0%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 100.0%
Jubilant Pharmova Limited 31.67 Billion INR 100.0%
Glenmark Life Sciences Limited 147.61 Million INR 100.0%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 100.0%
Divi's Laboratories Limited 20 Million INR 100.0%
NATCO Pharma Limited 53 Million INR 100.0%
Gufic Biosciences Limited 1.53 Billion INR 100.0%
IOL Chemicals and Pharmaceuticals Limited - INR NaN%
Ind-Swift Limited 10.09 Billion INR 100.0%
Procter & Gamble Health Limited 68.8 Million INR 100.0%
FDC Limited 2.46 Million INR 100.0%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 100.0%
Granules India Limited 689.71 Million INR 100.0%
Medicamen Biotech Limited 12.55 Million INR 100.0%
Alkem Laboratories Limited 400 Million INR 100.0%
AstraZeneca Pharma India Limited 27.83 Million INR 100.0%
Biofil Chemicals and Pharmaceuticals Limited - INR NaN%
Brooks Laboratories Limited 3.56 Million INR 100.0%
Megasoft Limited 1.35 Billion INR 100.0%
ZIM Laboratories Limited 356 Million INR 100.0%
Strides Pharma Science Limited 6.71 Billion INR 100.0%
Neuland Laboratories Limited 449.2 Million INR 100.0%
Morepen Laboratories Limited 33.64 Million INR 100.0%
Hikal Limited 4.22 Billion INR 100.0%
Indoco Remedies Limited 3.51 Billion INR 100.0%
Aarti Pharmalabs Limited 400 Thousand INR 100.0%
Kilitch Drugs (India) Limited - INR NaN%
Mangalam Drugs & Organics Limited 133.54 Million INR 100.0%
Hester Biosciences Limited 1.81 Billion INR 100.0%